NOVAD fund winners announced for study of diabetes and obesity

NOVAD fund winners announced for study of diabetes and obesity

The 3-year, $2.5 million fund is a partnership between the University of Alberta Hospital Foundation, the Government of Alberta, and Novo Nordisk Canada.


“These projects will help to identify gaps in care, an important first step to fuel future innovations that can change the trajectory of diabetes and obesity in Alberta,” said Iain Graham, President of Novo Nordisk Canada Inc. “We're proud to support these investigators whose research has the potential to have a positive impact on the health of Albertans.”


Dr. Diana Mager will use the funding to develop home-based strategies for frailty prevention in the community in adults with Diabetes and Chronic Kidney Disease.

Dr. Denise Campbell-Scherer will examine clinical and social determinants of health for both obesity and diabetes prevention and management in newcomer ethno-culture communities.

Dr. Padma Kaul will conduct a population-level study of social and clinical determinants of childhood obesity.

View the livestream of the announcement on Facebook and learn more about the NOVAD fund here.


Article by Catherine Griwkowsky, Taproot Edmonton